Compare GraniteShares 2x Long COIN Daily ETF (CONL) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GraniteShares 2x Long COIN Daily ETF vs Citius Pharmaceuticals Inc — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $4.15, while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Citius Pharmaceuticals Inc is trading nearer its 52-week high, GraniteShares 2x Long COIN Daily ETF nearer its low. Which is the better fit depends on your goals.
| CONL | CTXR | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $48.70 | $1.82 |
52-Week Low | $3.93 | $0.48 |
Market Cap | — | $20.01M |
Enterprise Value | — | $16.23M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GraniteShares 2x Long COIN Daily ETF
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
